In recent years, there is growing evidence that the activation of the PI3K/Akt path facilitates the improvement of cardiac fibrosis in models from ischemia/reperfusion to AMI and diabetic cardiomyopathy (20–22). The gene discussed is AKT1; the disease is ischemia.